The current P/E ratio for West Pharmaceutical Services stock as of Jan 22, 2025 is 51.08. This is calculated based on the TTM EPS of $6.81 and the stock price of $347.87 per share. The PE ratio has increased by 10% from its last 4 quarters average of 46.5.
The average historical PE ratio of West Pharmaceutical Services for the last ten years is 45.42. The current price-to-earnings ratio of 51.08 is 12% more than the historical average. Analyzing the last ten years, WST's PE ratio reached its highest point in the Sep 2020 quarter at 64.99, when the price was $274.9 and the EPS was $4.23. The lowest point was recorded in the Sep 2022 quarter, when it reached 29.19 with a price of $246.08 and an EPS of $8.43.
Maximum annual increase: 52.25% in 2015
Maximum annual decrease: -43.33% in 2022
Year | PE ratio | Change |
---|---|---|
2023 | 44.13 | 47.59% |
2022 | 29.9 | -43.33% |
2021 | 52.76 | -12.85% |
2020 | 60.54 | 31.69% |
2019 | 45.97 | 31.31% |
2018 | 35.01 | -27.62% |
2017 | 48.37 | 11.76% |
2016 | 43.28 | -4.42% |
2015 | 45.28 | 52.25% |
2014 | 29.74 | -2.4% |
The current PE ratio of WST is above its 3, 5 and 10-year averages.
WST's PE ratio is less than its peer stock BAX, but it is above JNJ's and SYK's. West Pharmaceutical Services's current PE ratio of 51.08 is more than the average of its peers, which is 33.68.
Stock name | PE ratio | Market cap |
---|---|---|
JNJ Johnson & Johnson | 24.09 | $349.76B |
MDT Medtronic plc | 26.7 | $112.64B |
TFX Teleflex Inc | 35.72 | $8.4B |
BDX Becton Dickinson & Co | 40.46 | $68.79B |
SYK Stryker Corp | 41.41 | $148.86B |
WST West Pharmaceutical Services Inc | 51.08 | $25.19B |
BAX Baxter International Inc | 151.57 | $16.25B |
ICUI Icu Medical Inc | N/A | $4.09B |
PLL Piedmont Lithium Inc | N/A | $165.22M |
As of Jan 22, 2025, WST stock has a price to earnings ratio of 51.08.
Over the last 3 years, the average PE ratio for WST stock is 43.14.
Over the last 5 years, the average PE ratio for WST stock is 47.7.
Over the last ten years, the quarterly PE ratio reached its highest level at 64.99 in the Sep 2020 quarter.
The current PE ratio of WST is 12% higher than the 10-year historical average.
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (Jan 22, 2025), West Pharmaceutical Services's share price is $347.87. The company's earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $6.81. Therefore, West Pharmaceutical Services's price to earnings ratio for today is 51.08. PE RATIO(51.08) = STOCK PRICE($347.87) / TTM EPS($6.81)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.